Castle Biosciences Inc (CSTL)
28.61
+0.57
(+2.03%)
USD |
NASDAQ |
Jan 03, 16:00
28.61
0.00 (0.00%)
After-Hours: 06:26
Castle Biosciences Research and Development Expense (Annual): 53.62M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Delcath Systems Inc | 17.50M |
CytoSorbents Corp | 15.73M |
CytomX Therapeutics Inc | 77.68M |
Spero Therapeutics Inc | 51.44M |
Progyny Inc | -- |